NIPT (Non-Invasive Prenatal Screening)
Safe and Early Prenatal Screening
PGT & Carrier Screening
Preconception Genetic Assessment
Molecular Genetics & NGS
High-Tech DNA Sequencing & Bioinformatics
Cancer Genetics & Oncology
Hereditary Cancer Risks & Oncology Panels
General Clinical Services
Clinical Follow-up, Counseling & Solutions
Cytogenetics & Karyotyping
Chromosome Analysis & Cytogenetic Solutions
Screening for common chromosomal abnormalities, including trisomies 21, 18 and 13, from maternal blood starting at 10 weeks.
General Genetic Tests
Onco-Hematology Panels
Corporate Profile
Ecegen Values, History & Admin Structure
Our Team & Careers
Expert Physicians and Career Opportunities
Quality & Support
ISO 15189 Standards & Frequently Asked Questions
Our corporate structure, mission, vision and values as Turkey's leading genetic diagnostics center.
Physician & Request Forms
Clinical Test Request & Analysis Documents
Patient Consent & Consultation Forms
Legal Consent, Counseling & Consultation
Digital and printable request forms for physicians ordering genetic analysis, NGS panels, or NIPT.
Press & Media
TV Broadcasts, Interviews & Scientific Conversations
News & Announcements
Latest Developments from ECEGEN
Scientific Blog
Genetic Science & Clinical Education Articles
A selection of ECEGEN television broadcasts, expert interviews, and scientific conversations.
Genetics & Science
Genetic diseases, diagnostic methods, and scientific developments in medicine.
A guide to FMF and recurrent fever and pain: the role of MEFV, the limitations of genetic testing, inheritance and regular follow-up.
A personalized mRNA vaccine produced long-lasting immune responses against pancreatic cancer in an early clinical study. Although encouraging, the approach remains experimental.
GLP-1 medicines can influence appetite and blood sugar regulation, but they are not suitable for everyone. We explain their effects, limitations, and why medical supervision matters.
A personalized gene-editing therapy was developed in about six months for a baby with a rare metabolic disease. Here is what this first case shows—and why it remains experimental.
The first FDA-cleared blood test for evaluating Alzheimer's disease may simplify part of the diagnostic pathway. It is not intended for screening or for making a diagnosis on its own.
An experimental gene therapy produced hearing gains in children with profound hearing loss caused by two disease-causing OTOF variants. The approach is promising but applies only to a specific genetic subtype.
Despite their massive size and long lifespans, elephants have much lower cancer rates than humans. In this article, we examine the role of the TP53 gene, known as the guardian of the genome, and Peto's Paradox.
